CohBar Inc - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of CohBar Inc can be accessed by logging in. If you are employed by CohBar Inc and you would like to use your Sustainability aseessment, please get in touch. The dashboard contains a questions and answers table on CohBar Inc.
CohBar Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 8.0.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 837 | Zentiva as | 4.7 | High |
| 837 | Zogenix Inc | 4.7 | High |
| 852 | CohBar Inc | 4.6 | High |
| 852 | Canopy Growth Corp | 4.6 | High |
| 852 | Novavax Inc | 4.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does CohBar Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes CohBar Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes CohBar Inc report the average age of the workforce?
Sign up for free to unlockDoes CohBar Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes CohBar Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes CohBar Inc disclose cybersecurity risks?
Sign up for free to unlockDoes CohBar Inc offer flexible work?
Sign up for free to unlockDoes CohBar Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes CohBar Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes CohBar Inc conduct supply chain audits?
Sign up for free to unlockDoes CohBar Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes CohBar Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes CohBar Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes CohBar Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes CohBar Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes CohBar Inc disclose water use targets?
Sign up for free to unlockDoes CohBar Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid CohBar Inc have a product recall in the last two years?
Sign up for free to unlockDoes CohBar Inc disclose incidents of discrimination?
Sign up for free to unlockDoes CohBar Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas CohBar Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes CohBar Inc disclose parental leave metrics?
Sign up for free to unlockDoes CohBar Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes CohBar Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes CohBar Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes CohBar Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes CohBar Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes CohBar Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs CohBar Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes CohBar Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes CohBar Inc disclose its waste policy?
Sign up for free to unlockDoes CohBar Inc report according to TCFD requirements?
Sign up for free to unlockDoes CohBar Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes CohBar Inc disclose energy use targets?
Sign up for free to unlockDoes CohBar Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes CohBar Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for CohBar Inc
These potential risks are based on the size, segment and geographies of the company.
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.